{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:57:55Z","timestamp":1766192275362,"version":"3.48.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF\\u20132025\\u201361"],"award-info":[{"award-number":["ORF\\u20132025\\u201361"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.pharma.2025.07.010","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T16:57:53Z","timestamp":1754413073000},"page":"78-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Crystal structure, spectral characterization, photophysical properties, Hirshfeld surface analysis, and antimicrobial activity of homopiperazinium dichromate(VI)"],"prefix":"10.1016","volume":"84","author":[{"given":"Utkirjon","family":"Holikulov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houda","family":"Marouani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Roisnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar M.","family":"Al-Dossary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abduvakhid","family":"Jumabaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureddine","family":"Issaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharma.2025.07.010_bib0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/fcp.12408","article-title":"Piperazine derivatives with central pharmacological activity used as therapeutic tools","volume":"33","author":"Brito","year":"2019","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharma.2025.07.010_bib0135","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00044-019-02398-2","article-title":"Design, synthesis, and biological evaluation of matrine derivatives possessing piperazine moiety as antitumor agents","volume":"28","author":"Xu","year":"2019","journal-title":"Med Chem Res"},{"key":"10.1016\/j.pharma.2025.07.010_bib0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejmech.2019.01.062","article-title":"Design, synthesis and anti-bacterial studies of piperazine derivatives against drug resistant bacteria","volume":"166","author":"Tahir","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.010_bib0145","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/14756366.2021.1931861","article-title":"Piperazine skeleton in the structural modification of natural products: a review","volume":"36","author":"Zhang","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.pharma.2025.07.010_bib0150","doi-asserted-by":"crossref","first-page":"130047","DOI":"10.1016\/j.molstruc.2021.130047","article-title":"Design, synthesis and molecular docking studies of novel piperazine metal complexes as potential antibacterial candidate against MRSA","volume":"1232","author":"Prasad","year":"2021","journal-title":"J Mol Struct"},{"issue":"5","key":"10.1016\/j.pharma.2025.07.010_bib0155","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.saa.2008.12.037","article-title":"Synthesis of new piperazine derived Cu (II)\/Zn (II) metal complexes, their DNA binding studies, electrochemistry and anti-microbial activity: validation for specific recognition of Zn (II) complex to DNA helix by interaction with thymine base","volume":"72","author":"Tabassum","year":"2009","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.pharma.2025.07.010_bib0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10847-009-9709-4","article-title":"Synthesis and characterization of novel calix [4] arenepiperazine derivative for the extraction of transition metals and dichromate ions","volume":"67","author":"Minhas","year":"2010","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"10.1016\/j.pharma.2025.07.010_bib253","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.molstruc.2018.06.041","article-title":"Synthesis, molecular structure, vibrational and theoretical studies of a new non-centrosymmetric organic sulphate with promising NLO properties","volume":"1171","author":"Mleh","year":"2018","journal-title":"J Mol Struct"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.010_bib0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1021\/jo01060a031","article-title":"A novel synthesis of homopiperazine and its monomethyl derivatives","volume":"26","author":"Poppelsdorf","year":"1961","journal-title":"J Org Chem"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.010_bib0170","doi-asserted-by":"crossref","first-page":"M1200","DOI":"10.3390\/M1200","article-title":"Homopiperazine (hexahydro-1, 4-diazepine)","volume":"2021","author":"Aitken","year":"2021","journal-title":"Molbank"},{"year":"2018","series-title":"U.S. Patent No. 10,112, 912","author":"Valde","key":"10.1016\/j.pharma.2025.07.010_bib0175"},{"issue":"12","key":"10.1016\/j.pharma.2025.07.010_bib0180","doi-asserted-by":"crossref","first-page":"105292","DOI":"10.1016\/j.arabjc.2023.105292","article-title":"Recent advances in the piperazine based antiviral agents: a remarkable heterocycle for antiviral research","volume":"16","author":"Walayat","year":"2023","journal-title":"Arab J Chem"},{"key":"10.1016\/j.pharma.2025.07.010_bib0185","doi-asserted-by":"crossref","first-page":"110392","DOI":"10.1016\/j.inoche.2023.110392","article-title":"Molecular docking and biological studies of the Cu (II) and Ni (II) macroacyclic complexes with 1, 4-bis (o-aminobenzyl)-1, 4-diazacycloheptane, a ligand containing the homopiperazine moiety","volume":"149","author":"Keypour","year":"2023","journal-title":"Inorg Chem Commun"},{"issue":"36","key":"10.1016\/j.pharma.2025.07.010_bib0190","doi-asserted-by":"crossref","first-page":"10942","DOI":"10.1021\/acs.jafc.2c00726","article-title":"Applications of isosteres of piperazine in the design of biologically active compounds: part 1","volume":"70","author":"Meanwell","year":"2022","journal-title":"J Agric Food Chem"},{"issue":"14","key":"10.1016\/j.pharma.2025.07.010_bib0195","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2174\/0929867325666171123203550","article-title":"Histamine H3 receptor ligands in the group of (homo) piperazine derivatives","volume":"25","author":"Szczepanska","year":"2018","journal-title":"Curr Med Chem"},{"issue":"51","key":"10.1016\/j.pharma.2025.07.010_bib0200","doi-asserted-by":"crossref","first-page":"32907","DOI":"10.1021\/acsomega.0c03495","article-title":"A mechanistic investigation on the anticancer properties of sya013, a homopiperazine analogue of haloperidol with activity against triple negative breast cancer cells","volume":"5","author":"Asong","year":"2020","journal-title":"ACS omega"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.010_bib0205","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2174\/15734064113096660050","article-title":"Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity","volume":"10","author":"Kuder","year":"2014","journal-title":"Med Chem"},{"key":"10.1016\/j.pharma.2025.07.010_bib0210","first-page":"100020","article-title":"Pharmacomodulations around an anti-Alzheimer drug-candidate","volume":"4","author":"Marc","year":"2022","journal-title":"Eur J Med Chem Rep"},{"key":"10.1016\/j.pharma.2025.07.010_bib0215","series-title":"Crystal explorer","first-page":"3","author":"Wolff","year":"2012"},{"issue":"5","key":"10.1016\/j.pharma.2025.07.010_bib0220","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1107\/S2056989016005284","article-title":"Crystal structure of 1, 4-bis (3-ammoniopropyl) piperazine-1, 4-diium bis [dichromate(VI)]","volume":"72","author":"Vetrivel","year":"2016","journal-title":"Acta Crystallogr E Crystallogr Commun"},{"key":"10.1016\/j.pharma.2025.07.010_bib0225","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11224-020-01671-0","article-title":"Crystal structure and vibrational spectra of salts of 1H-pyrazole-1-carboxamidine and its protonation route","volume":"32","author":"Rejnhardt","year":"2021","journal-title":"Struct Chem"},{"issue":"8","key":"10.1016\/j.pharma.2025.07.010_bib0230","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/cryst13081193","article-title":"Coordination polymers with a pyrazine-2, 5-diyldimethanol Linker: Supramolecular networks through hydrogen and halogen bonds","volume":"13","author":"Armaghan","year":"2023","journal-title":"Crystals"},{"key":"10.1016\/j.pharma.2025.07.010_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2023.102645","article-title":"Investigations on the non-covalent interactions, drug-likeness, molecular docking and chemical properties of 1,1,4,7,7-pentamethyldiethylenetriammonium trinitrate by density-functional theory","volume":"35","author":"Medimagh","year":"2023","journal-title":"J. King Saud Univ Sci"},{"key":"10.1016\/j.pharma.2025.07.010_bib0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-2860(93)80024-P","article-title":"Vibrational spectra of hexaaqua complexes III. Internal and external motions of the water molecules in the spectra of [Cr (H2O) 6] Cl3","volume":"293","author":"Stefov","year":"1993","journal-title":"J Mol Struct"},{"key":"10.1016\/j.pharma.2025.07.010_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08204","article-title":"Impact of non-covalent interactions on FT-IR spectrum and properties of 4-methylbenzylammonium nitrate. A DFT and molecular docking study","volume":"7","author":"Medimagh","year":"2021","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.010_bib0240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/jcat.1997.1518","article-title":"Diffuse reflectance spectroscopy of supported chromium oxide catalysts: a self-modeling mixture analysis","volume":"166","author":"Weckhuysen","year":"1997","journal-title":"J Catal"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.010_bib0245","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0025-5408(68)90023-8","article-title":"Optical properties and electronic structure of amorphous Ge and Si","volume":"3","author":"Tauc","year":"1968","journal-title":"Mater Res Bull"},{"key":"10.1016\/j.pharma.2025.07.010_bib0250","doi-asserted-by":"crossref","first-page":"131311","DOI":"10.1016\/j.molstruc.2021.131311","article-title":"Molecular structure, spectroscopy, quantum chemical and antibacterial activity investigations of 2-methylbenzylammonium perchlorate","volume":"1247","author":"Daghar","year":"2022","journal-title":"J Mol Struct"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:56:59Z","timestamp":1766192219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450925001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0003450925001166"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2025.07.010","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crystal structure, spectral characterization, photophysical properties, Hirshfeld surface analysis, and antimicrobial activity of homopiperazinium dichromate(VI)","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2025.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}